This White Paper provides a foundational understanding of insights management, including the definition and value of insights, processes and technologies for insights management, and key challenges in implementation.
In this webinar, a roundtable of experienced Medical Affairs leaders will discuss the opportunities and challenges evolving within their field, as well as the impact it can have on delivering great patient outcomes.
The objectives of this webinar are to present alternate views on a particular issue that is of concern to the Medical Affairs community while also attempting to resolve the issue.
This article outlines the aspects of Medical Affairs strategy and launch excellence specific to supporting the development and launch of treatments targeting rare diseases, providing a roadmap for MA teams and organizations undertaking this planning.
This webinar discusses the leadership role that Medical Affairs plays in the development and execution of a cross-functional launch plan. An upcoming gene therapy launch will provide real-life examples of how Medical Affairs can be an effective strategic leader through launch planning.
In this episode, MAPS speaks with Mark Michalski, former radiologist and currently Worldwide Head, Healthcare & Life Sciences, Artificial Intelligence and Machine Learning, Amazon Web Services about how we can catch up with big tech in our ability to mine data for meaning.
In Q&A format, this article summarizes key learnings from a MAPS 2022 Global Annual Meeting panel presented by the Medical Strategy FAWG.
This webinar, a continuation from April 27, analyzes the future of Medical Affairs in Japan while discussing what we can do together to make Medical Affairs in Japan even more effective.
This white paper by the MAPS Executive Consortium synthesizes the views of senior global Medical Affairs leaders to provide a unified vision for the future of Medical Affairs in society, industry, teams and as individuals.
This webinar shows how identifying areas of opportunity with current available data, and pushing teams to put our patients at the center of our efforts, we can begin implementing novel impact methodologies.